{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:39:38Z","timestamp":1772120378460,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.arbres.2016.10.021","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T22:02:54Z","timestamp":1484172174000},"page":"245-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["La diabetes se asocia con reacciones adversas graves en la tuberculosis multirresistente"],"prefix":"10.1016","volume":"53","author":[{"given":"Marcela","family":"Mu\u00f1oz-Torrico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Caminero-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Battista","family":"Migliori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Carrillo-Alduenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Villareal-Velarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Torres-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Flores-Vergara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Mart\u00ednez-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Garc\u00eda-Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosella","family":"Centis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Salazar-Lezama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogelio","family":"P\u00e9rez-Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2016.10.021_bib0195","unstructured":"World Health Organization. Global Tuberculosis Report 2015. WHO\/HTM\/TB\/2015.22. Geneva: World Health Organization; 2015."},{"key":"10.1016\/j.arbres.2016.10.021_bib0200","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 7th ed.; 2015 [consultado 2 Ago 2016]. Disponible en: www.diabetesatlas.org"},{"key":"10.1016\/j.arbres.2016.10.021_bib0205","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies","volume":"5","author":"Jeong","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.arbres.2016.10.021_bib0210","unstructured":"Secretar\u00eda de Salud de M\u00e9xico. Gu\u00eda para la atenci\u00f3n de personas con tuberculosis resistente a f\u00e1rmacos. Ciudad de M\u00e9xico; 2010."},{"key":"10.1016\/j.arbres.2016.10.021_bib0215","unstructured":"Plataforma \u00danica de Informaci\u00f3n\/SUIVE\/DGE\/SS 2012- 06\/06\/2013 DGIS CUBOS 2011 [consultado 2 Ago 2016]. Disponible en: https:\/\/www.sinave.gob.mx"},{"key":"10.1016\/j.arbres.2016.10.021_bib0220","doi-asserted-by":"publisher","first-page":"e0129312","DOI":"10.1371\/journal.pone.0129312","article-title":"Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012","volume":"10","author":"Delgado-S\u00e1nchez","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.arbres.2016.10.021_bib0225","unstructured":"TB CARE I. International standards for tuberculosis care, Edition 3. TB CARE I, The Hague; 2014."},{"key":"10.1016\/j.arbres.2016.10.021_bib0230","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1183\/09031936.00203811","article-title":"European Union standards for tuberculosis care","volume":"39","author":"Migliori","year":"2012","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2016.10.021_bib0235","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"Caminero","year":"2010","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.arbres.2016.10.021_bib0240","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency Update 2008. WHO\/HTM\/TB 2008.402. Geneva: World Health Organization; 2008."},{"key":"10.1016\/j.arbres.2016.10.021_bib0245","unstructured":"Guidelines for the programmatic management of drug-resistant tuberculosis. 2011 Update. WHO\/HTM\/TB 2011.6. Geneva: World Health Organization; 2011."},{"key":"10.1016\/j.arbres.2016.10.021_bib0250","unstructured":"World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO\/HTM\/TB\/2014.11. Geneva: World Health Organization; 2014."},{"key":"10.1016\/j.arbres.2016.10.021_bib0255","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1183\/13993003.00438-2016","article-title":"Efficacy and tolerability of ethionamide versus prothionamide: A systematic review","volume":"48","author":"Scardigli","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2016.10.021_bib0260","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1183\/09031936.00022912","article-title":"Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: Systematic review and meta-analysis","volume":"40","author":"Sotgiu","year":"2012","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2016.10.021_bib0265","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1183\/09031936.00145014","article-title":"Linezolid to treat MDR-\/XDR-tuberculosis: Available evidence and future scenarios","volume":"45","author":"Sotgiu","year":"2015","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2016.10.021_bib0270","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1183\/13993003.00649-2015","article-title":"Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment","volume":"46","author":"Winters","year":"2015","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2016.10.021_bib0275","doi-asserted-by":"publisher","first-page":"514","DOI":"10.5588\/ijtld.12.0167","article-title":"Drug resistance in Mexico: Results from the National Survey on Drug-Resistant Tuberculosis","volume":"17","author":"Boj\u00f3rquez-Chapela","year":"2013","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.arbres.2016.10.021_bib0280","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/S0140-6736(12)60727-2","article-title":"Scaling up interventions to achieve global tuberculosis control: Progress and new developments","volume":"379","author":"Raviglione","year":"2012","journal-title":"Lancet."},{"key":"10.1016\/j.arbres.2016.10.021_bib0285","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","article-title":"The impact of diabetes on tuberculosis treatment outcomes: A systematic review","volume":"9","author":"Baker","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.arbres.2016.10.021_bib0290","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MAJ.0b013e318288f8f3","article-title":"Impact of diabetes mellitus on treatment outcomes of tuberculosis patients in a tertiary care setup","volume":"345","author":"Sulaiman","year":"2013","journal-title":"Am J Med Sci."},{"key":"10.1016\/j.arbres.2016.10.021_bib0295","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4269\/ajtmh.2009.80.634","article-title":"Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis","volume":"80","author":"Dooley","year":"2009","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.arbres.2016.10.021_bib0300","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.diabres.2016.07.023","article-title":"Death in patients with tuberculosis and diabetes: Associated factors","volume":"120","author":"Dos Santos Feltrin","year":"2016","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.arbres.2016.10.021_bib0305","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1378\/chest.120.5.1514","article-title":"Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997","volume":"120","author":"Bashar","year":"2001","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2016.10.021_bib0310","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/thoraxjnl-2012-201756","article-title":"Association of diabetes and tuberculosis: Impact on treatment and post-treatment outcomes","volume":"68","author":"Jim\u00e9nez-Corona","year":"2013","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2016.10.021_bib0315","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1128\/AAC.01345-13","article-title":"Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus","volume":"57","author":"Babalik","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.arbres.2016.10.021_bib0320","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1086\/507543","article-title":"Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes","volume":"43","author":"Nijland","year":"2006","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.arbres.2016.10.021_bib0325","first-page":"648","article-title":"Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis","volume":"5","author":"Furin","year":"2001","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.arbres.2016.10.021_bib0330","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ."},{"issue":"11-12","key":"10.1016\/j.arbres.2016.10.021_bib0335","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1080\/00365540802342372","article-title":"Type 2 diabetes and multidrug-resistant tuberculosis","volume":"40","author":"Fisher-Hoch","year":"2008","journal-title":"Scand J Infect Dis."},{"key":"10.1016\/j.arbres.2016.10.021_bib0340","doi-asserted-by":"crossref","first-page":"610","DOI":"10.5588\/ijtld.11.0544","article-title":"Treatment of multidrug-resistant tuberculosis in a high-prevalence region through a binational consortium","volume":"16","author":"Laniado-Labor\u00edn","year":"2012","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.arbres.2016.10.021_bib0345","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.4269\/ajtmh.2010.10-0145","article-title":"Outcomes of multidrug-resistant tuberculosis among binational cases in El Paso, Texas","volume":"83","author":"Ferrer","year":"2010","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.arbres.2016.10.021_bib0350","doi-asserted-by":"publisher","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","article-title":"Treatment outcomes of multidrug-resistant tuberculosis: A systematic review and meta-analysis","volume":"4","author":"Johnston","year":"2009","journal-title":"PLoS One."},{"key":"10.1016\/j.arbres.2016.10.021_bib0355","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","article-title":"Treatment outcomes among patients with multidrug-resistant tuberculosis: Systematic review and meta-analysis","volume":"9","author":"Orenstein","year":"2009","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.arbres.2016.10.021_bib0360","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1183\/09031936.00136312","article-title":"Drug resistance beyond extensively drug-resistant tuberculosis: Individual patient data meta-analysis","volume":"42","author":"Migliori","year":"2013","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2016.10.021_bib0365","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Resistance to fluoroquinolones and second-line injectable drugs: Impact on multidrug-resistant TB outcomes","volume":"42","author":"Falzon","year":"2013","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2016.10.021_bib0370","unstructured":"Secretar\u00eda de Salud. Modificaci\u00f3n a la Norma Oficial Mexicana. NOM-006-SSA2-1993. Para la prevenci\u00f3n y control de la tuberculosis en la atenci\u00f3n primaria a la salud. Diario Oficial de la Federaci\u00f3n, 2013 [consultado 2 Ago 2016]. Disponible en: http:\/\/www.salud.gob.mx\/unidades\/cdi\/nom\/m006ssa23.html"},{"key":"10.1016\/j.arbres.2016.10.021_bib0375","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1183\/09031936.00204611","article-title":"Tuberculosis: Cost of illness in Germany","volume":"40","author":"Diel","year":"2012","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2016.10.021_bib0380","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1183\/09031936.00079413","article-title":"Costs of tuberculosis disease in the European Union: A systematic analysis and cost calculation","volume":"43","author":"Diel","year":"2014","journal-title":"Eur Respir J."}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289616303374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289616303374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T08:19:17Z","timestamp":1568708357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289616303374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0300289616303374"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2016.10.021","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La diabetes se asocia con reacciones adversas graves en la tuberculosis multirresistente","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2016.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}